Compare · HQL vs OWL
HQL vs OWL
Side-by-side comparison of abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) and Blue Owl Capital Inc. (OWL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HQL and OWL operate in Investment Managers (Finance), so they compete in similar markets.
- OWL is the larger of the two at $15.28B, about 32.4x HQL ($471.0M).
- OWL has been more active in the news (13 items in the past 4 weeks vs 1 for HQL).
- OWL has more recent analyst coverage (25 ratings vs 0 for HQL).
abrdn Life Sciences Investors Shares of Beneficial Interest
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Blue Owl Capital Inc.
Blue Owl Capital Inc. operates as an asset manager. The company provides investors access to direct lending and GP capital solutions strategies through various vehicles. Its breadth of offerings and permanent capital base enables it to offer a holistic platform of capital solutions to participants throughout the private market ecosystem, including alternative asset managers and private middle market corporations. The company is based in New York, New York.
Latest HQL
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Director Mahai Chris Lavictoire bought $10,498 worth of shares (527 units at $19.92) (SEC Form 4)
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form 3 filed by new insider Mahai Chris Lavictoire
- SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Latest OWL
- Co-Chief Executive Officer Lipschultz Marc S was granted 789,775 units of Class C Shares (SEC Form 4)
- Co-President Packer Craig was granted 730,542 units of Class C Shares (SEC Form 4)
- Co-Chief Executive Officer Ostrover Douglas I was granted 789,775 units of Class C Shares (SEC Form 4)
- Co-President Zahr Marc was granted 789,775 units of Class C Shares (SEC Form 4)
- Co-President Rees Michael Douglass was granted 1,046,859 units of Class C Shares (SEC Form 4)
- General Counsel and Secretary Reddy Neena sold $419,037 worth of Class A Shares (40,292 units at $10.40), decreasing direct ownership by 7% to 575,892 units (SEC Form 4)
- Blue Owl Technology Finance Corp. Announces September 30, 2026 Financial Results
- Blue Owl Capital Corporation Announces September 30, 2026 Financial Results
- SEC Form 10-Q filed by Blue Owl Capital Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Blue Owl Capital Inc.